Notch is out — your watchlist beside the MacBook notch, synced with this account.
Learn more ↗We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
EPS -0.13 · 매출 755.7만. 세부 수치와 가이던스는 원문에서 확인하세요.
EPS 컨센서스 -0.12 · 매출 컨센서스 1156.3만. 발표 후 실제치와 비교하세요.
EPS -0.18 · 매출 1381.9만. 세부 수치와 가이던스는 원문에서 확인하세요.
신규 편입 · 포트폴리오 비중 0.00%
신규 편입 · 포트폴리오 비중 0.00%
EPS -0.07 · 매출 1444.6만. 세부 수치와 가이던스는 원문에서 확인하세요.
매출 1301.5만. 세부 수치와 가이던스는 원문에서 확인하세요.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
EPS -0.14 · 매출 1280.7만. 세부 수치와 가이던스는 원문에서 확인하세요.
Consensus vs. actual, and revenue trend
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| FY2026 Q3 | 2026. 09. 30. | Time TBD | — | $-0.13 | — | — | $7.56M | Reported |
| — | 2026. 08. 11. | After market close (AMC) | $-0.12 | — | — | $11.56M | — | Scheduled |
| FY2026 Q2 | 2026. 06. 30. | Time TBD | — | $-0.18 | — | — | $13.82M | Reported |
| FY2026 Q1 | 2026. 03. 31. | Time TBD | — | $-0.07 | — | — | $14.45M | Reported |
Consensus PT $9.33 · 9 analysts
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2025. 11. 07. | Piper Sandler | — | Maintain | Overweight → Overweight | — | Piper Sandler: Overweight |
| 2025. 10. 09. | JMP Securities | — | Maintain | Market Outperform → Market Outperform | — | JMP Securities: Market Outperform |
| 2025. 09. 08. | Oppenheimer | — | Maintain | Outperform → Outperform | — | Oppenheimer: Outperform |
| 2025. 06. 17. | HC Wainwright & Co. | — | Maintain | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2025. 05. 15. | HC Wainwright & Co. | — | Maintain | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2025. 04. 02. | HC Wainwright & Co. | — | Maintain | Buy → Buy | — | HC Wainwright & Co.: Buy |
